A Prospective Study on the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma

Status: Not yet recruiting

Phase of Trial: Phase II

Latest Information Update: 04 Aug 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Nedaplatin (Primary) ; Paclitaxel (Primary) ; Toripalimab (Primary)
Indications Carcinoma; Oesophageal cancer; Squamous cell cancer; Thoracic neoplasms
Focus Therapeutic Use

19 Aug 2021 Planned initiation date changed from 31 May 2021 to 31 Dec 2021.
21 May 2021 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com